Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Review Article Volume 6 Issue 1

Virtual and on Site Vaccination Clinics of COVID-19. Will it be Applicable?

Sara AR2, Mohamed Raslan1,2, Eslam MS2 and Nagwa A Sabri1*

1Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
2Drug Research Centre, Cairo, Egypt

*Corresponding Author: Nagwa A Sabri, Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

Received: December 03, 2021; Published: December 24, 2021

Abstract

Background: As a result of production and manufacturing of COVID-19 vaccines, mass vaccination and immunization will become critical part in controlling covid-19 spreading. The present vaccination facilities and strategies are not optimized for the most effective clinical and infection control methods.

Aim: Highlight the current vaccination approaches and to suggest some proposals to enhance the quality and increase the capacity of vaccination system. 

Method: The current immunization procedures situation were addressed and proposals of some additional approaches for improving the process and to maintain infection control procedures to the best practices.

Conclusion: To acquire immunity in a short amount of time, vulnerable persons should be mass vaccinated. This will bring the COVID-19 epidemic under control, reducing the load on health-care institutions and the requirement for hospitalization dramatically. The suggested changes to the present vaccination system, as well as prior experiences, will assist in providing immunization services while protecting people's safety.

Keywords: Covid-19; Clinical Pharmacist; SARS-CoV-2; Immunization; Vaccination

References

  1. Cascella M., et al. “Features, Evaluation and Treatment Coronavirus (COVID-19)”. in StatPearls. Treasure Island, FL: StatPearls Publishing LLC (2020).
  2. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 10223 (2020): 497-506.
  3. Nagwa Ali Sabri., et al. “Depressive Disorders and Incidence of COVID-19: Is There a Correlation and Management Interference?” Psychological Disorders and Research2 (2020): 3-7.
  4. Asgary A., et al. “A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic”. Healthcare (Basel) 4 (2020): 469.
  5. Li JY., et al. “The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future”. Microbes Infectious2 (2020): 80-85.
  6. Nagwa A Sabri., et al. “Impact of Applied Protective Measures of COVID-19 on Public Health". Acta Scientific Pharmaceutical Sciences7 (2020): 63-72.
  7. Melissa W McClung., et al. “Managing public health data: mobile applications and mass vaccination campaigns”. Journal of the American Medical Informatics Association4 (2018): 435-439.
  8. Pate J. “Drive-Thru PODs: An Alternate Method of Mass Prophylaxis”. Public Health Preparedness Summit; Washington, DC, USA (2007).
  9. Carrico R. “Drive-Thru Flu Shots—A Model for Mass Immunization”. Spectrum Press; Chicago, IL, USA (2002).
  10. Knox D. In: Davenport, Dispensing Emergency Medications and Supplies. Fielding J.E., Teutsch S.M., editors. Oxford University Press; Oxford, UK: (2012): 243-253.
  11. Pate J. “Drive-Thru PODs: An Alternate Method of Mass Prophylaxis”. Public Health Preparedness Summit; Washington, DC, USA (2007).
  12. Lee EK., et al. “Modeling and Optimizing the Public-Health Infrastructure for Emergency Response”. Interfaces 39 (2009): 476-490.
  13. Wessex Local Medical Committees. “Operational Aspects of Influenza Immunisation 2020/21”. Wessex Local Medical Committees; Eastleigh, UK (2020).
  14. Lobna S Mostafa., et al. “Evaluation of pharmacist-led educational interventions to reduce medication errors in emergency hospitals: a new insight into patient care”. Journal of Public Health1 (2020): 169-174.

Citation

Citation: Nagwa A Sabri., et al. “Virtual and on Site Vaccination Clinics of COVID-19. Will it be Applicable?". Acta Scientific Pharmaceutical Sciences 6.1 (2022): 141-144.

Copyright

Copyright: © 2022 Nagwa A Sabri., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US